|
1
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Islam F, Gopalan V, Smith RA and Lam AK:
Translational potential of cancer stem cells: A review of the
detection of cancer stem cells and their roles in cancer recurrence
and cancer treatment. Exp Cell Res. 335:135–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferenczy A and Franco E: Persistent human
papillomavirus infection and cervical neoplasia. Lancet Oncol.
3:11–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tindle RW: Immune evasion in human
papillomavirus-associated cervical cancer. Nat Rev Cancer. 2:59–65.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chhabra R: Cervical cancer stem cells:
Opportunities and challenges. J Cancer Res Clin Oncol.
141:1889–1897. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
López J, Valdez-Morales FJ,
Benitez-Bribiesca L, Cerbón M and Carrancá AG: Normal and cancer
stem cells of the human female reproductive system. Reprod Biol
Endocrinol. 11:532013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Herfs M, Yamamoto Y, Laury A, Wang X,
Nucci MR, McLaughlin-Drubin ME, Münger K, Feldman S, McKeon FD,
Xian W and Crum CP: A discrete population of squamocolumnar
junction cells implicated in the pathogenesis of cervical cancer.
Proc Natl Acad Sci USA. 109:10516–10521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Letian T and Tianyu Z: Cellular receptor
binding and entry of human papillomavirus. Virol J. 7:22010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pyeon D, Pearce SM, Lank SM, Ahlquist P
and Lambert PF: Establishment of human papillomavirus infection
requires cell cycle progression. PLoS Pathog. 5:e10003182009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Quade BJ, Yang A, Wang Y, Sun D, Park J,
Sheets EE, Cviko A, Federschneider JM, Peters R, McKeon FD and Crum
CP: Expression of the p53 homologue p63 in early cervical
neoplasia. Gynecol Oncol. 80:24–29. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sell S: On the stem cell origin of cancer.
Am J Pathol. 176:2584–2494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martens JE, Arends J, Van der Linden PJ,
De Boer BA and Helmerhorst TJ: Cytokeratin 17 and p63 are markers
of the HPV target cell, the cervical stem cell. Anticancer Res.
24:771–775. 2004.PubMed/NCBI
|
|
13
|
Mighty KK and Laimins LA: p63 is necessary
for the activation of human papillomavirus late viral functions
upon epithelial differentiation. J Virol. 85:8863–8869. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Z, Oron E, Nelson B, Razis S and
Ivanova N: Distinct lineage specification roles for NANOG, OCT4 and
SOX2 in human embryonic stem cells. Cell Stem Cell. 10:440–454.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hattori N, Imao Y, Nishino K, Hattori N,
Ohgane J, Yagi S, Tanaka S and Shiota K: Epigenetic regulation of
Nanog gene in embryonic stem and trophoblast stem cells. Genes
Cells. 12:387–396. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye F, Zhou C, Cheng Q, Shen J and Chen H:
Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are
highly expressed in malignant cervical epithelial cells. BMC
cancer. 8:1082008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu D, Zhou P, Zhang L, Wu G, Zheng Y and
He F: Differential expression of Oct4 in HPV-positive and
HPV-negative cervical cancer cells is not regulated by DNA
methyltransferase 3A. Tumour Biol. 32:941–950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li SW, Wu XL, Dong CL, Xie XY, Wu JF and
Zhang X: The differential expression of OCT4 isoforms in cervical
carcinoma. PLoS One. 10:e01180332015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yao T, Chen Q, Zhang B, Zhou H and Lin Z:
The expression of ALDH1 in cervical carcinoma. Med Sci Monit.
17:HY21–HY26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rao QX, Yao TT, Zhang BZ, Lin RC, Chen ZL,
Zhou H, Wang LJ, Lu HW, Chen Q, Di N and Lin ZQ: Expression and
functional role of ALDH1 in cervical carcinoma cells. Asian Pac J
Cancer Prev. 13:1325–1331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu SY and Zheng PS: High aldehyde
dehydrogenase activity identifies cancer stem cells in human
cervical cancer. Oncotarget. 4:2462–2475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J and Zhou BP: Activation of
beta-catenin and Akt pathways by Twist are critical for the
maintenance of EMT associated cancer stem cell-like characters. BMC
Cancer. 11:492011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin J, Liu X and Ding D: Evidence for
epithelial-mesenchymal transition in cancer stem-like cells derived
from carcinoma cell lines of the cervix uteri. Int J Clin Exp
Pathol. 8:847–855. 2015.PubMed/NCBI
|
|
24
|
Saslow D, Runowicz CD, Solomon D, Moscicki
AB, Smith RA, Eyre HJ and Cohen C: American Cancer, Society:
American Cancer Society guideline for the early detection of
cervical neoplasia and cancer. CA Cancer J Clin. 52:342–362. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pecorelli S, Benedet JL, Creasman WT and
Shepherd JH: FIGO staging of gynecologic cancer. 1994–1997 FIGO
Committee on Gynecologic Oncology. International Federation of
Gynecology and Obstetrics. Int J Gynaecol Obstet. 65:243–249. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mason DY: Immunocytochemical analysis of
human tissueOxford Textbook of Pathology. Oxford University Press;
Oxford: 2. pp. 2275–2284. 1992
|
|
28
|
Ping YF and Bian XW: Consice review:
Contribution of cancer stem cells to neovascularization. Stem
Cells. 29:888–894. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Facompre N, Nakagawa H, Herlyn M and Basu
D: Stem-like cells and therapy resistance in squamous cell
carcinomas. Adv Pharmacol. 65:235–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Patel P and Chen EI: Cancer stem cells,
tumor dormancy, and metastasis. Front Endocrinol (Lausanne).
3:1252012.PubMed/NCBI
|
|
31
|
Andrews TE, Wang D and Harki DA: Cell
surface markers of cancer stem cells: Diagnostic macromolecules and
targets for drug delivery. Drug Deliv Transl Res. 3:121–142. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xia P: Surface markers of cancer stem
cells in solid tumors. Curr Stem Cell Res Ther. 9:102–111. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Allegra A, Alonci A, Penna G, Innao V,
Gerace D, Rotondo F and Musolino C: The cancer stem cell
hypothesis: A guide to potential molecular targets. Cancer Invest.
32:470–495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sladek NE: Human aldehyde dehydrogenases:
Potential pathological, pharmacological, and toxicological impact.
J Biochem Mol Toxicol. 17:7–23. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chute JP, Muramoto GG, Whitesides J,
Colvin M, Safi R, Chao NJ and McDonnell DP: Inhibition of aldehyde
dehydrogenase and retinoid signaling induces the expansion of human
hematopoietic stem cells. Proc Natl Acad Sci USA. 103:11707–11712.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marcato P, Dean CA, Giacomantonio CA and
Lee PW: Aldehyde dehydrogenase: Its role as a cancer stem cell
marker comes down to the specific isoform. Cell Cycle.
10:1378–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tomita H, Tanaka K, Tanaka T and Hara A:
Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget.
7:11018–11032. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Le Magnen C, Bubendorf L, Rentsch CA,
Mengus C, Gsponer J, Zellweger T, Rieken M, Thalmann GN, Cecchini
MG, Germann M, et al: Characterization and clinical relevance of
ALDHbright populations in prostate cancer. Clin Cancer Res.
19:5361–5371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kurashige T, Shimamura M, Yasui K,
Mitsutake N, Matsuse M, Nakashima M, Minami S, Eguchi S and
Nagayama Y: Studies on the expression of aldehyde dehydrogenase in
normal and cancerous tissues of thyroids. Horm Metab Res.
47:194–199. 2015.PubMed/NCBI
|
|
40
|
Wu S, Xue W, Huang X, Yu X, Luo M, Huang
Y, Liu Y, Bi Z, Qiu X and Bai S: Distinct prognostic values of
ALDH1 isoenzymes in breast cancer. Tumour Biol. 36:2421–2426. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Patel M, Lu L, Zander DS, Sreerama L, Coco
D and Moreb JS: ALDH1A1 and ALDH3A1 expression in lung cancers:
Correlation with histologic type and potential precursors. Lung
Cancer. 59:340–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hou T, Zhang W, Tong C, Kazobinka G, Huang
X, Huang Y and Zhang Y: Putative stem cell markers in cervical
squamous cell carcinoma are correlated with poor clinical outcome.
BMC Cancer. 15:7852015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yao T, Wu Z, Liu Y, Rao Q and Lin Z:
Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor
prognosis in cervical cancer. J Int Med Res. 42:1038–1042. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xie Q, Liang J, Rao Q, Xie X, Li R, Liu Y,
Zhou H, Han J, Yao T and Lin Z: Aldehyde dehydrogenase 1 expression
predicts chemoresistance and poor clinical outcomes in patients
with locally advanced cervical cancer treated with neoadjuvant
chemotherapy prior to radical hysterectomy. Ann Surg Oncol.
23:163–170. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen X, Xu H, Yuan P, Fang F, Huss M, Vega
VB, Wong E, Orlov YL, Zhang W, Jiang J, et al: Integration of
external signaling pathways with the core transcriptional network
in embryonic stem cells. Cell. 133:1106–1117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim J, Chu J, Shen X, Wang J and Orkin SH:
An extended transcriptional network for pluripotency of embryonic
stem cells. Cell. 132:1049–1061. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zeineddine D, Hammoud AA, Mortada M and
Boeuf H: The Oct4 protein: More than a magic stemness marker. Am J
Stem Cells. 3:74–82. 2014.PubMed/NCBI
|
|
48
|
Boyer LA, Lee TI, Cole MF, Johnstone SE,
Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG,
et al: Core transcriptional regulatory circuitry in human embryonic
stem cells. Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rizzino A: Concise review: The Sox2-Oct4
connection: Critical players in a much larger interdependent
network integrated at multiple levels. Stem Cells. 31:1033–1039.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liedtke S, Stephan M and Kögler G: Oct4
expression revisited: Potential pitfalls for data misinterpretation
in stem cell research. Biol Chem. 389:845–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang YJ and Herlyn M: The emerging roles
of Oct4 in tumor-initiating cells. Am J Physiol Cell Physiol.
309:C709–C718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang YD, Cai N, Wu XL, Cao HZ, Xie LL and
Zheng PS: OCT4 promotes tumorigenesis and inhibits apoptosis of
cervical cancer cells by miR-125b/BAK1 pathway. Cell Death Dis.
4:e7602013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Echelman D and Feldman S: Management of
cervical precancers: a global perspective. Hematol Oncol Clin North
Am. 26:31–44. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kim BW, Cho H, Choi CH, Ylaya K, Chung JY,
Kim JH and Hewitt SM: Clinical significance of OCT4 and SOX2
protein expression in cervical cancer. BMC Cancer. 15:10152015.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liu D, Zhou P, Zhang L, Zheng Y and He F:
HPV16 activates the promoter of Oct4 gene by sequestering HDAC1
from repressor complex to target it to proteasomal degradation. Med
Hypotheses. 79:531–534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tyagi A, Vishnoi K, Mahata S, Verma G,
Srivastava Y, Masaldan S, Roy BG, Bharti AC and Das BC: Cervical
cancer stem cells selectively overexpress HPV oncoprotein E6 that
controls stemness and self-renewal through upregulation of HES1.
Clin Cancer Res. 22:4170–4184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yang MH, Imrali A and Heeschen C:
Circulating cancer stem cells: The importance to select. Clin
Cancer Res. 27:437–449. 2015.
|
|
58
|
Cao YT, Li JH, Wang YT, Fu YW and Xu J:
Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell
lung cancer. Tumori. 100:214–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sladek NE, Kollander R, Sreerama L and
Kiang DT: Cellular levels of aldehyde dehydrogenases (ALDH1A1 and
ALDH3A1) as predictors of therapeutic responses to
cyclophosphamide-based chemotherapy of breast cancer: A
retrospective study. Rational individualization of
oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer
Chemother Pharmacol. 49:309–321. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chang TS, Wu YC, Chi CC, Su WC, Chang PJ,
Lee KF, Tung TH, Wang J, Liu JJ, Tung SY, et al: Activation of
IL6/IGFIR confers poor prognosis of HBV-related hepatocellular
carcinoma through induction of OCT4/NANOG expression. Clin Cancer
Res. 21:201–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Bobryshev YV, Orekhov AN and Chistiakov
DA: Vascular stem/progenitor cells: Current status of the problem.
Cell Tissue Res. 362:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Krenning G, Barauna VG, Krieger JE,
Harmsen MC and Moonen JR: Endothelial plasticity: Shifting
phenotypes through force feedback. Stem Cells Int.
2016:97629592016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Minhajat R, Nilasari D and Bakri S: The
role of endothelial progenitor cell in cardiovascular disease risk
factors. Acta Med Indones. 47:340–347. 2015.PubMed/NCBI
|
|
64
|
Gu W, Hong X, Potter C, Qu A and Xu Q:
Mesenchymal stem cells and vascular regeneration. Microcirculation.
24:2017.doi: 10.1111/micc.12324. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Sherman SE, Kuljanin M, Cooper TT, Putman
DM, Lajoie GA and Hess DA: High aldehyde dehydrogenase activity
identifies a subset of human mesenchymal stromal cells with
vascular regenerative potential. Stem Cells. 35:1542–1553. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Constantinescu S: Stemness, fusion and
renewal of hematopoietic and embryonic stem cells. J Cell Mol Med.
7:103–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hattori N, Imao Y, Nishino K, Hattori N,
Ohgane J, Yagi S, Tanaka S and Shiota K: Epigenetic regulation of
Nanog gene in embryonic stem and trophoblast stem cells. Genes
Cells. 12:387–396. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
69
|
Suzuke L, Peng YH, Zhou K, et al: The
analysis of pathogenetic tendency of cervical cancer in various
ethnic women in Xinjiang. J Xinjiang Med Univ. 29:569–571. 2006.(In
Chinese).
|
|
70
|
Abudoukadeer A, Niyazi M, Aikula A,
Kamilijian M, Sulaiman X, Mutailipu A and Abudula A: Association of
EBV and HPV co-infection with the development of cervical cancer in
ethnic Uyghur women. Eur J Gynaecol Oncol. 36:546–550.
2015.PubMed/NCBI
|
|
71
|
Zhang GQ, LIU KJ, Lai XJ, et al:
Distribution of malignant tumor patients in hospital from 1989 to
2002 in the Affiliated Tumor Hospital of Xinjiang Medical
University. J Xinjiang Med Univ. 26:393–395. 2003.(In Chinese).
|
